CRA
ROCKVILLE, Md.--(BW HealthWire)--Jan. 29, 2001--
Deal Includes Researchers at Ten California Campuses and Three U.S.
Department of Energy National Laboratories Managed by UC
Celera Genomics (NYSE:CRA), an Applera Corporation business,
announced today it signed a multi-year agreement with the University
of California (UC) system allowing UC investigators access to all of
Celera's database products. The UC system encompasses ten campuses
throughout California and three national laboratories -- Lawrence
Berkeley National Laboratory, Lawrence Livermore National Laboratory
and Los Alamos National Laboratory. The UC subscribers will access
Celera's database information through its Celera Discovery System(TM).
Financial terms of the agreements were not disclosed.
"This agreement with the University of California system is
personally very gratifying because I earned my Ph.D. in physiology and
pharmacology at UC San Diego in 1975," said J. Craig Venter, Ph.D.,
Celera's president and chief scientific officer. "UC is one of the
world's largest higher education systems whose scientists are
recognized leaders in public research. I believe that access to
Celera's online portfolio of comparative genomic and genetic variation
information as well as the tools, software and computing power to
analyze these data, should advance medical research at UC and
worldwide."
"The faculty of the University of California has a long history of
working at the leading edge of science," said UC Provost Judson King.
"Celera's genome databases should ensure that our researchers have the
best tools to forge the frontiers of comparative genetics, evolution,
biochemistry and medicine as well as to educate the future scientific
leaders in these disciplines."
The Celera Discovery System is an integrated, web-based discovery
system that allows subscribers to use Celera generated databases,
additional non-proprietary genome and biological datasets,
computational tools and super-computing power to advance the discovery
programs of researchers worldwide.
About the Regents of the University of California
With a student body of over 170,000 students and a research budget
of approximately $2 billion, the University of California is one of
the largest educational and research institutions in the world. The UC
system also operates the nation's largest medical research and
training program comprised of 14 health science schools located on six
campuses.
About Celera
Applera Corporation, formerly PE Corporation, comprises two
operating groups. The Celera Genomics Group, headquartered in
Rockville, MD, intends to be the definitive source of genomic and
related medical information. Celera has developed three business
units: the On-line Information Business, Discovery Sciences, and
Discovery Services, all of which build upon Celera's generation,
integration, and analysis of biological information. Celera intends to
enable therapeutic discoveries both through its own application of its
scientific capabilities and in partnership with pharmaceutical and
biotechnology companies. The Applied Biosystems Group (NYSE:ABI)
develops and markets instrument-based systems, reagents, software, and
contract services to the life science industry and research community.
Customers use these tools to analyze nucleic acids (DNA and RNA) and
proteins in order to make scientific discoveries, develop new
pharmaceuticals, and conduct standardized testing. Applied Biosystems
is headquartered in Foster City, CA, and reported sales of $1.4
ROCKVILLE, Md.--(BW HealthWire)--Jan. 29, 2001--
Deal Includes Researchers at Ten California Campuses and Three U.S.
Department of Energy National Laboratories Managed by UC
Celera Genomics (NYSE:CRA), an Applera Corporation business,
announced today it signed a multi-year agreement with the University
of California (UC) system allowing UC investigators access to all of
Celera's database products. The UC system encompasses ten campuses
throughout California and three national laboratories -- Lawrence
Berkeley National Laboratory, Lawrence Livermore National Laboratory
and Los Alamos National Laboratory. The UC subscribers will access
Celera's database information through its Celera Discovery System(TM).
Financial terms of the agreements were not disclosed.
"This agreement with the University of California system is
personally very gratifying because I earned my Ph.D. in physiology and
pharmacology at UC San Diego in 1975," said J. Craig Venter, Ph.D.,
Celera's president and chief scientific officer. "UC is one of the
world's largest higher education systems whose scientists are
recognized leaders in public research. I believe that access to
Celera's online portfolio of comparative genomic and genetic variation
information as well as the tools, software and computing power to
analyze these data, should advance medical research at UC and
worldwide."
"The faculty of the University of California has a long history of
working at the leading edge of science," said UC Provost Judson King.
"Celera's genome databases should ensure that our researchers have the
best tools to forge the frontiers of comparative genetics, evolution,
biochemistry and medicine as well as to educate the future scientific
leaders in these disciplines."
The Celera Discovery System is an integrated, web-based discovery
system that allows subscribers to use Celera generated databases,
additional non-proprietary genome and biological datasets,
computational tools and super-computing power to advance the discovery
programs of researchers worldwide.
About the Regents of the University of California
With a student body of over 170,000 students and a research budget
of approximately $2 billion, the University of California is one of
the largest educational and research institutions in the world. The UC
system also operates the nation's largest medical research and
training program comprised of 14 health science schools located on six
campuses.
About Celera
Applera Corporation, formerly PE Corporation, comprises two
operating groups. The Celera Genomics Group, headquartered in
Rockville, MD, intends to be the definitive source of genomic and
related medical information. Celera has developed three business
units: the On-line Information Business, Discovery Sciences, and
Discovery Services, all of which build upon Celera's generation,
integration, and analysis of biological information. Celera intends to
enable therapeutic discoveries both through its own application of its
scientific capabilities and in partnership with pharmaceutical and
biotechnology companies. The Applied Biosystems Group (NYSE:ABI)
develops and markets instrument-based systems, reagents, software, and
contract services to the life science industry and research community.
Customers use these tools to analyze nucleic acids (DNA and RNA) and
proteins in order to make scientific discoveries, develop new
pharmaceuticals, and conduct standardized testing. Applied Biosystems
is headquartered in Foster City, CA, and reported sales of $1.4
Fred |
